Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality
- 31 July 2010
- journal article
- review article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2), 193-198
- https://doi.org/10.1016/j.jsbmb.2010.03.064
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Multiple Acquired Renal Carcinoma Tumor Capabilities Abolished upon Silencing of ADAM17Cancer Research, 2006
- Tumor Necrosis Factor-α-converting Enzyme (TACE/ADAM-17) Mediates the Ectodomain Cleavage of Intercellular Adhesion Molecule-1 (ICAM-1)Published by Elsevier BV ,2006
- A critical role for enhanced TGF-α and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney diseaseAmerican Journal of Physiology-Renal Physiology, 2005
- Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approachNature Medicine, 2005
- Transforming Growth Factor Alpha (TGF-α) and Other Targets of Tumor Necrosis Factor-Alpha Converting Enzyme (TACE) in Murine Polycystic Kidney DiseasePediatric Research, 2005
- Activated Injectable Vitamin D and Hemodialysis SurvivalJournal of the American Society of Nephrology, 2005
- Functional Cooperation between CCAAT/Enhancer-Binding Proteins and the Vitamin D Receptor in Regulation of 25-Hydroxyvitamin D3 24-HydroxylaseMolecular and Cellular Biology, 2005
- Selective Roles for Tumor Necrosis Factor α-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand FamilyPublished by Elsevier BV ,2004
- 1α-Hydroxylase transactivation by γ-interferon in murine macrophages requires enhanced C/EBPβ expression and activationThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-α-converting Enzyme (ADAM 17)Published by Elsevier BV ,2003